Gastroparesis Lawsuit Filed Over Side Effects of Ozempic and Trulicity
Despite reported problems dating back to 2010, Novo Nordisk failed to warn doctors and users of Ozempic and Trulicity about the risk of gastroparesis, lawsuit warns.
Despite reported problems dating back to 2010, Novo Nordisk failed to warn doctors and users of Ozempic and Trulicity about the risk of gastroparesis, lawsuit warns.
New York woman indicates she had to undergo an emergency resection of her bowels and now needs to use a colostomy bag as a result of gastroparesis and intestinal obstructions from Mounjaro
Illinois woman required multiple emergency visits due to an Ozempic intestinal blockage, according to a lawsuit filed against the drug maker over inadequate warnings provided about the potential stomach side effects
The FDA has reportedly seized thousands of fake Ozempic products over the last year, the report indicates.
Novo Nordisk faces lawsuits over inadequate warnings about stomach paralysis caused by Ozempic and Wegovy, which outline how the GLP-1 semaglutide may permanently alter the stomach’s natural digestive function.
Mississippi man indicates he was hospitalized multiple times due to gastroparesis side effects from Mounjaro, which occurred after only a few months of receiving the diabetes and weight loss injections.
Plaintiff notes that Novo Nordisk failed to include gastroparesis or its side effects in the "Warnings and Precautions" section of Ozempic drug label.
Pennsylvania woman was taken off of the Ozempic injections after her stomach pains and constant vomiting symptoms were linked to gastroparesis, also known as stomach paralysis.
Many of the incidents involved overdoses with compounded versions of Ozempic and Wegovy's active ingredient, semaglutide.
Plaintiff says Novo Nordisk downplayed the potential stomach paralysis side effects from Ozempic, by failing to accurately describe the extent of the risk on the medication's label and prescribing information.